During emergency surgery for a craniotomy hematoma on a (b)(6) year-old patient, a full unit of surgiflo was used.Postoperative bleeding occurred.The surgeon commented that the patient was hypertensive, and the hematoma was quite large, wherefore he doesn't think the postoperative bleeding was linked to surgiflo.The present event is most likely caused by the clinical condition of the patient, rather than the product, as noted by the surgeon.Note that the instructions for use for surgiflo states: "as with other gelatin hemostatic agents that swell, this device should be used with caution in neurosurgery.Safe and effective use of this device in neurosurgery has not been proven through randomised, controlled studies.".There is no information on patient outcome, post-op consequences or interventions, wherefore follow-up questions have been sent.Although it is unlikely that the event is linked to surgiflo, it cannot be excluded to have a contributary role.(b)(4).
|